HDL and LDL: potential new players in breast cancer development

L Cedó, ST Reddy, E Mato, F Blanco-Vaca… - Journal of clinical …, 2019 - mdpi.com
Breast cancer is the most prevalent cancer and primary cause of cancer-related mortality in
women. The identification of risk factors can improve prevention of cancer, and obesity and …

Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs

KK Patel, K Kashfi - Biochemical pharmacology, 2022 - Elsevier
Cholesterol is an amphipathic sterol molecule that is vital for maintaining normal
physiological homeostasis. It is a relatively complicated molecule with 27 carbons whose …

Involvement of LDL and ox-LDL in cancer development and its therapeutical potential

CF Deng, N Zhu, TJ Zhao, HF Li, J Gu, DF Liao… - Frontiers in …, 2022 - frontiersin.org
Lipid metabolism disorder is related to an increased risk of tumorigenesis and is involved in
the rapid growth of cancer cells as well as the formation of metastatic lesions …

Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy

X Li, Z Liu, Y Wu, H Wu, W Dai, B Arshad, Z Xu… - Lipids in health and …, 2018 - Springer
Background The lipid profile status among breast cancer patients at initial diagnosis and
during chemotherapy remain controversial. The aim of this study is to study the status of lipid …

LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies

G Revilla, L Cedó, M Tondo, A Moral, JI Pérez… - Seminars in cancer …, 2021 - Elsevier
Cholesterol is essential for a variety of functions in endocrine-related cells, including
hormone and steroid production. We have reviewed the progress to date in research on the …

Applications of microfluidics and microchip electrophoresis for potential clinical biomarker analysis

JV Pagaduan, V Sahore, AT Woolley - Analytical and bioanalytical …, 2015 - Springer
This article reviews advances over the last five years in microfluidics and microchip-
electrophoresis techniques for detection of clinical biomarkers. The variety of advantages of …

Is cholesterol a risk factor for breast cancer incidence and outcome?

CB Hassen, C Goupille, C Vigor, T Durand… - The Journal of Steroid …, 2023 - Elsevier
Cholesterol plays important roles in many physiological processes, including cell membrane
structure and function, hormone synthesis, and the regulation of cellular homeostasis. The …

Circulating 27-hydroxycholesterol, lipids, and steroid hormones in breast cancer risk: a nested case–control study of the Multiethnic Cohort Study

MC DeRouen, J Yang, Y Li, AA Franke, AN Tome… - Breast Cancer …, 2023 - Springer
Background Laboratory studies have indicated that a cholesterol metabolite and selective
estrogen receptor modulator, 27-hydroxycholesterol (27HC), may be important in breast …

Zingiberene exerts chemopreventive activity against 7, 12‐dimethylbenz (a) anthracene‐induced breast cancer in Sprague‐Dawley rats

VD Seshadri, AAA Oyouni, WM Bawazir… - … of Biochemical and …, 2022 - Wiley Online Library
Breast cancer is the primary cause of cancer‐related death in females, wherein increased
mortality of breast cancer patients is recorded worldwide. Zingiberene is a monocyclic …

[HTML][HTML] Impact of cholesterol-pathways on breast cancer development, a metabolic landscape

A González-Ortiz, O Galindo-Hernández… - Journal of …, 2021 - ncbi.nlm.nih.gov
ApoB-lipoproteins and their components modulate intracellular metabolism and have been
associated with the development of neoplastic phenomena, such as proliferation, anchorage …